Sintx Technologies (SINT) Liabilities and Shareholders Equity (2013 - 2026)

Sintx Technologies' (SINT) quarterly Liabilities and Shareholders Equity came in at $7.8 million in Q1 2026, down 31.78% year-on-year from $11.4 million in Q1 2025, and down 17.83% quarter-over-quarter from $9.5 million in Q4 2025.

Sintx Technologies (SINT) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Sintx Technologies' Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $7.8 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 31.78% year-over-year to $7.8 million in Q1 2026; TTM through Mar 2026 was $37.9 million, a 20.2% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, up 0.99% from the prior year.
  • Liabilities and Shareholders Equity declined to $7.8 million in Q1 2026 per SINT's latest filing, from $9.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $22.7 million in Q1 2023 and bottomed at $7.8 million in Q1 2026.
  • The 5-year median for Liabilities and Shareholders Equity is $15.3 million (2024), against an average of $14.2 million.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 41.44% in 2022 and climbed 19.95% in 2023, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $15.8 million in 2022, then slipped by 2.59% to $15.4 million in 2023, then sank by 38.74% to $9.4 million in 2024, then increased by 0.99% to $9.5 million in 2025, then retreated by 17.83% to $7.8 million in 2026.
  • Per Business Quant, the three latest SINT Liabilities and Shareholders Equity figures stand at $7.8 million (Q1 2026), $9.5 million (Q4 2025), and $11.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Sintx Technologies 17,274.80 -1.87 Mn 144,000.00 7.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.81 Mn
Dec 31, 2025 9.51 Mn
Sep 30, 2025 11.36 Mn
Jun 30, 2025 9.20 Mn
Mar 31, 2025 11.45 Mn
Dec 31, 2024 9.41 Mn
Sep 30, 2024 11.30 Mn
Jun 30, 2024 15.30 Mn
Mar 31, 2024 17.56 Mn
Dec 31, 2023 15.37 Mn
Sep 30, 2023 15.51 Mn
Jun 30, 2023 19.10 Mn
Mar 31, 2023 22.65 Mn
Dec 31, 2022 15.77 Mn
Sep 30, 2022 14.56 Mn
Jun 30, 2022 17.49 Mn
Mar 31, 2022 18.88 Mn
Dec 31, 2021 21.84 Mn
Sep 30, 2021 24.87 Mn
Jun 30, 2021 26.42 Mn